/b/veterinary-news/posts/new-treatment-for-canine-oa-secures-funding-for-trials Stevenage-based pharmaceutical company AKL Research and Development has announced it has signed an agreement with one of the world’s top five animal health companies to fund the development of its next-stage clinical trial of an investigational drugen-USTelligent Community 10